Tetraploid (4N) complementation assay is regard as the most stringent characterization test for the pluripotency of embryonic stem (ES) cells. The technology can generate mice fully derived from the injected ES cell (ES-4N) with 4N placentas. However, it remains a very inefficient procedure owing to a lack of information on the optimal conditions for ES incorporation into the 4N embryos. In the present study, we injected ES cells from embryos of natural fertilization (fES) and somatic cell nuclear transfer (ntES) into 4N embryos at various stages of development to determine the optimal stage of ES cells integration by comparing the efficiency of full-term ES-4N mouse generation. Our results demonstrate that fES/ntES cells can be incorporated into 4N embryos at 2-cell, 4-cell and blastocyst stages and fullterm mice can be generated. Interestingly, ntES cells injected into the 4-cell group resulted in the lowest efficiency (5.6%) compared to the 2-cell (13.8%, P . 0.05) and blastocyst (16.7%, P , 0.05) stages. Because 4N embryos start to form compacted morulae at the 4-cell stage, we investigated whether the lower efficiency at this stage was due to early compaction by injecting ntES cells into artificially de-compacted embryos treated with calcium free medium. Although the treatment changed the embryonic morphology, it did not increase the efficiency of ES-4N mice generation. Immunochemistry of the cytoskeleton displayed microtubule and microfilament polarization at the late 4-cell stage in 4N embryos, which suggests that de-compaction treatment cannot reverse the polarization process. Taken together, we show here that a wide developmental range of 4N embryos can be used for 4N complementation and embryo polarization and compaction may restrict incorporation of ES cells into 4N embryos. assisted reproductive technology, developmental biology, early development, embryo, embryo compaction, embryonic stem cell, nuclear-transfer embryonic stem cell, tetraploid complementation assay
INTRODUCTION
Tetraploid complementation assay is a unique embryology technique in which aggregation of two tetraploid (4N) embryos with stem cell clumps (Sandwich method) or introduction of stem cells directly into 4N blastocysts [1] (blastocyst injection) results in the formation of 2N-4N chimeric embryos. The placental portion of the chimera will be composed of 4N cells, while the fetal portion will be composed of the injected ES cells (ES-4N mice) [2] . Using 4N complementation, ES-4N mice have been derived from embryonic stem (ES) cells from fertilized embryos (fES) [3] , from somatic cell nuclear transferred embryos (ntES) [4] , and from induced pluripotent stem (iPS) cells [5, 6] . Tetraploid complementation is considered the most stringent criterion in the verification of the pluripotency of stem cells [7] . Unfortunately, the inefficient rate of full-term ES-4N mice generation has restricted its widespread applications and the interpretation of the pluripotency results.
Previously, numerous attempts have been made to improve the efficiency of diploid (2N) chimera generation. For example, 2N embryos at four-cell and eight-cell stages were tested as host embryos for the generation of F0 chimera by the conventional microinjection method [8] or with laser [3] or piezo [9] device assistance. These studies demonstrated that introducing ES cells into embryos at earlier stages than the conventionally used blastocysts facilitates ES cells' contribution to tissues. However, there has been no systematic studies determining the optimal stage of 4N embryos for stem cell incorporation in 4N complementation. Therefore, the first goal of this study is to compare the efficiencies of full-term ES-4N mice generation by using 4N embryos at the two-and four-cell stages, with the 4N blastocysts serving as controls.
At the morula stage, blastomeres compact and begin to gain polarity and redistribute cytoskeleton structures to the apex of the cells. 4N embryos start to form compacted morula earlier than 2N embryos (four-cell vs. eight-cell stage). Therefore, we next injected ntES cells into artificially decompacted embryos that were treated with calcium-free medium at the four-cell stage to study the effects of prolonged embryo decompaction on the efficiency of full-term ES-4N pup generation.
MATERIALS AND METHODS

Chemicals
Unless otherwise indicated, all chemicals were purchased from SigmaAldrich (St. Louis, MO).
Animals and Generation of Tetraploid Embryos
All animal use and handling procedures were approved by the Institutional Animal Care and Use Committee at the University of Connecticut.
Eight-to 12-wk-old CD1 females (Charles River Laboratory) were used for both embryo transfer recipients and embryo donors. Naturally cycling female mice were mated with vasectomized males to generate pseudopregnant mice as embryo transfer recipients. To generate tetraploid (4N) embryos, superovulation was induced by injection of 7.5 IU eCG, followed by a 7.5 IU hCG injection and mating with CD1 males 48 h later. Two-cell stage zygotes (E1.5) were harvested and subjected to electropulses (150V/mm, 50 lsec, two pulses) to fuse the two blastomeres [4] . The resultant fused embryos were cultured in KSOM-AA medium at 378C in 5% CO 2 for 24 h to two-cell and four-cell stages and for 48 h to the blastocyst stage.
To confirm the success of electrofusion, karyotyping was conducted on the presumed 4N embryos. Briefly, 2N and presumable 4N embryos were first cultured to the blastocyst stage and then further cultured for 6 h in KSOM-AA plus 0.5 lg/ml nocodazole to synchronize the embryonic cells at metaphase. After transferring embryos into hypotonic solution of 1% sodium citrate for 10 min and then 3:1 methanol:glacial acetic acid for fixation, the embryos were dropped onto glass slides and stained with Giemsa to examine the chromosome numbers.
Maintenance and Characterization of ntES Cells
C57BL /6 ntES [4] and LDLr KO ntES cells were derived in our lab from nuclear transfer embryos derived from tail-tip fibroblasts of regular C57BL/6 male (Charles River Laboratory) and Ldlr tm1Her male (JAX stock#002207, mouse strain: nearly C57BL/6), respectively. R1 DsRed ES cells were derived from fertilized embryos (fES) [10] and served as controls of ntES cells in this study. In order to visualize ES cell incorporation, the R1 ES cells were transfected with DsRed gene (pIRES2-DsRed2, Clontech, CA), and stable cell lines were selected on the basis of G418 drug resistance and relatively strong red fluorescent expression level. All fES and ntES cells were cultured in ES medium [4] to maintain undifferentiated morphology and passaged every 3 days.
Before 4N complementation studies, ntES cells were characterized in vitro for alkaline phosphatase (AP) activity and stage-specific embryonic antigen-1 (FUT4) expression. NtES cells were seeded onto gelatinized 12-mm round cover slip plated with mouse embryonic fibroblasts (MEF) for 2-3 days until ES colonies were formed. Cells were incubated with AP staining solution (Vector Red AP substrate kit I) at room temperature for 30 min in the dark. After staining, samples were washed by buffer for 5 min, dehydrated by 99.5% ethanol for 5 min, and then treated with Vectashield with DAPI (Vector Laboratories) mounting solution. Slides were observed by Nikon TE300 microscope with flour and image analysis (MVI) using DIC lenses. The positive control was the characterized C57BL/6 ntES cells [4] , and the negative controls were the same cell line 96 h after LIF withdrawal, which was negative AP stain, as well as feeder cells. Flow cytometry was conducted to characterize the expression of ES cell surface markers, SSEA-1 (official symbol FUT4). NtES cells were trypsinized and dissociated into single cell suspension and plated onto gelatinized dishes for 30 min to remove feeder cells. Unattached ntES cells were then blocked by DPBS with 2% BSA for 15 min at room temperature. Cell lines were divided into two groups and stained with 10 lg/ml SSEA-1 (FUT4) monoclonal antibody (MAB4301; Millipore) or isotype control (IgM negative control, MABC008; Millipore) individually for 30 min on ice. After washing with DPBS, the secondary antibody (Alexa fluor 488-conjugated goat anti-mouse IgM, A21042; Invitrogen) was used. Cells were washed and suspended in DPBS for flow cytometry analysis. Flow cytometry was performed on a FACSCalibur flow cytometer equipped with CellQuest 3.1 (Becton Dickinson). Cells (10 4 ) were collected at each batch; cell debris, dead cells and doublets were excluded by properly gating on forward/side scatter. FUT4/isotype expression signals were both acquired from FL1-H channel. The positive controls were a previously characterized B6 ntES cell line [4] . For the negative control, the secondary AB was replaced by the monoclonal IgM for outer membrane protein 1 of various strains of Neisseria gonorrhoeae.
Immunocytochemistry was conducted as previously reported [4] by using ES-specific markers: OCT 4 ([POU5F1] sc-9081; Santa Cruz Biotechnology), NANOG (N3038), SOX2 (ab-5603; Millipore), and SSEA-1 (FUT4). Cell nuclei were counterstained by ToPro-3 iodide dye (T3605; Invitrogen) and mounted in Prolong gold antifade reagent (P36930; Invitrogen). Immunostained samples were observed and analyzed using a laser-scanning confocal microscope (Leica TCS SP2).
Generation of ES-4N Clonal Embryos and Mice by Injection of fES/ntES Cells into 4N Embryos
The culture medium of fES/ntES cells was refreshed 2 h prior to trypsinization treatment [8] . Ten to 15 fES or ntES cells were injected into the perivitelline space of 4N embryos at the two-and four-cell stages, and 15 to 20 fES/ntES cells were injected into the blastocoel of the 4N blastocysts with piezo (Prime Tech) assistance. An additional control, R1-DsRed ES cells injected into 2N blastocysts, was also conducted. The injected two-and fourcell stage 4N embryos were cultured in KSOM-AA plus 4% ES medium for 24 h [8] and then transferred into the uterus horns of E2.5 pseudopregnant mice; the injected blastocyst stage embryos were transferred into E2.5 pseudopregnant after 1-2 h of recovery from microinjection. C-section was performed at E18.5, residual implantation sites were visible at E18.5, and clonal fetuses were counted; body and placenta weights of ES-4N pups were measured.
Immunochemistry and Decompaction Treatment of 4N Embryos at Late Four-Cell Stage
For immunocytochemistry, various stages of 4N embryos were fixed and permeabilized with 2% formaldehyde, 1 lM taxol, 10 units/ml aprotinin, 50% deuterium oxide, and 0.5% Triton X-100 medium at 378C for 30 min. They were then washed and blocked in washing buffer (DPBS plus 2% BSA solution, 3 mM NaN 3 , 0.01% Triton X-100, 0.2% nonfat dry milk, 2% normal goat serum, 0.1 M glycine) at 48C overnight. Monoclonal antibody recognizing mouse a-tubulin (T 5168) was used for 1 h at 378C, then washed by washing buffer and labeled by Alexa Fluor 488 donkey anti-mouse IgG. Staining of microfilament was conducted by incubation with rhodamine-phallodin for 1 h at 378C according to Suzuki et al. [11] . Immunostained samples were mounted on slides with Vectashield antifading medium. Images were acquired with a laser-scanning confocal microscope (Leica TCS SP2) and analyzed by Leica LCS Lite software. Specimens were excited at 488 and 543 nm under 403 oil objectives and an additional 23 magnification with an electronic zoom.
Tetraploid embryos at the late four-cell to early compacted morula stages were exposed to calcium-free DPBS with 0.1% PVA for 5 min until clear boundary of blastomeres could be observed. NtES cells were injected into the perivitelline spaces of decompacted embryos. Injected embryos were cultured in KSOM-AA medium for 24 h and transferred to pseudopregnant mice.
Statistical Analysis
Statistical analysis was performed using the ''Cross Tabulation and ChiSquare'' functions of the Minitab software.
RESULTS
In Vitro and In Vivo Development of 4N Embryos with Injected fES/ntES Cells
Traditionally, 4N embryos at the blastocyst stage are used for injection of ES cells, possibly because of the easy of injection to the blastoceol. Tetraploid embryos (Fig. 1, A and  B) , however, have accelerated development [1] because of fusion, and it is possible that earlier-stage 4N embryos may serve as better hosts for the injected ES cells. Therefore, we selected two-cell and four-cell stage embryos (Fig. 1C) at 24 h postelectrofusion and blastocysts (controls; Fig. 1D ) at 48 h postelectrofusion for ntES cell injection with piezo pulses (Fig.  1, E and F) . The injected ntES cells were seen accumulating in between blastomeres (Fig. 1, E 0 and F 0 ). On the other hand, the injected 4N blastocysts (Fig. 1G ) exhibited shrunken blastocoels, and the ntES cells stayed inside the cavities (Fig. 1G 0 ). We then monitored whether the injected ES cells are capable of contributing to the developing chimeric embryos because of the use of earlier stage 4N host embryos. For this we used a well-established pluripotent fES cell line, R1, which were transfected with the DsRed gene and constitutively expressed a red fluorescence (Fig. 2) , for in vitro and in vivo observations of integration. During in vitro development, the injected fES cells, as shown by the red fluorescence, survived at both 4 and 19 h after injection. After 4 h of in vitro culture, the injected embryos recovered and proceeded further development: the two-cell group developed to four cells (Fig. 2C) , the four-cell group formed compacted morulae (Fig. 2D) , and the injected blastocysts reformed blastocoel cavities (Fig. 2E) . Nineteen hours after fES cell injection, compacted morula were widely observed in the two-cell group, and morulae changed to blastocysts in the four-cell group and expanded to hatching blastocyst embryos formed in the blastocyst group. Cells emitting red fluorescence were located outside of the 4N blastomeres in most of the embryos at 4 h postinjection, while after 19 h of in vitro culture, red fluorescent cells were observed inside the embryos in all three groups (Fig. 2, F-H) , revealing that the injected fES cells survived and incorporated into 4N host embryos at all three stages used despite the differences in ploidy and developmental stages.
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For the in vivo development, we transferred injected embryos into pseudopregnant mice. ES-4N fetuses were recovered after C-section at E12.5 from two-cell (Fig. 3, A and A 0 ), four-cell (Fig. 3, B and B 0 ), and blastocyst (data not shown) injection groups. Black eyes in all ES-4N fetuses (Fig.  3, A and B) were observed, indicating that these fetuses were derived form the R1 fES cells, which have different coat and eye colors from the albino CD1 4N host embryos and surrogate mothers. Additionally, we also observed red fluorescent signal in the entire embryo proper and extraembryonic mesoderm instead of the trophoblast tissue, which was derived from the 4N host embryos (Fig. 3, A  0 and B 0 ). In contrast to the unique expressions of red fluorescence from all ES-4N fetuses, the 2N chimera generated as controls revealed a different ES incorporation pattern. Chimeric mice that had black eyes showed red fluorescence, indicating that ES cells incorporated to a certain extent in the fetal portion (Fig. 3 , C and C 0 ); however, chimeric mice that did not show black pigmentation of the eyes showed faint or no red fluorescence, indicating a low level to a lack of chimerism (Fig. 3, D To identify the optimal stage of host 4N embryos for 4N complementation, rates of full-term ES-4N mice generation need to be compared. Prior to the in vivo experiments, we characterized the ES cell used, LDLr KO ntES cells. Flow cytometry analysis for FUT4 expression after immunostaining (Fig. 4B) revealed no difference when compared to a wellcharacterized ntES cell line, C57BL/6 ntES (Fig. 4A) . Alkaline phosphatase analysis (Fig. 4 , E and E 0 ) also showed bright red substrate precipitation signals as strong as the C57BL/6 ntES cells (Fig. 4, D and D 0 ). Immunocytochemistry of ES pluripotent markers revealed that the LDLr KO ntES cells could express nuclear-specific factors such as POU5F1 (Fig.  4G) , NANOG (Fig. 4G 0 ), and SOX 2 (Fig. 4H) . Mouse ESspecific surface marker, FUT4, was also positive on cell membranes (Fig. 4H  0 ) . These results confirmed that LDLr KO We then performed 4N complementation experiments by injecting LDLr KO ntES cells into CD-1 4N two-cell, four-cell, and blastocyst stage embryos followed by embryo transfer. The number of residual implantation sites viable at E18.5 in the uterus, stillborn fetuses, and full-term ntES-4N pups on Csections at E18.5 are summarized in Table 1 . We successfully generated ntES-4N pups from all three groups. We noticed a significantly lower percentage of success on residual implantation sites and full-term pups from the four-cell group than the other groups. The blastocyst group gave the highest rate of ntES-4N pups generation (16.7%) based on the number of transferred embryos, including 10 pups from one recipient mouse alone after C-section (Figs. 5A and 2A 0 and A 00 ). Most of ntES-4N pups showed normal fetal and placental weights regardless of the stage of the host 4N embryos used. The average ES-4N pup body and placenta weights from the LDLr KO ntES cell line were 1.17 6 0.14 and 0.14 6 0.05 g, respectively (Fig. 5B) . Among all fetuses, only one placenta hypertrophy (0.26 g) was observed in the four-cell group. However, this weight was still less than the average (0.28 g, n ¼ 6; unpublished observations) weight we observed for cloned mice, which are frequently reported as having large offspring syndrome.
ES-4N MICE FROM ES CELLS INJECTED TO VARIOUS STAGE
FIG. 3. Degrees of R1 DsRed ES cell integration into the developing fetuses at E12.5 after injection into tetraploid (4N) and diploid (2N) embryos. A and B) ES-4N fetuses generated from injection of R1 DsRed ES cells into two-cell (A and
Decompaction Treatment of 4N Embryos Did Not Alter Cellular Polarity or ntES Cell Incorporation
To investigate why the four-cell group gave the lowest efficiency of ntES-4N pup generation, we considered the onset of embryo compaction in the late four-cell stage 4N embryos, which is faster than that the 2N embryos (eight-cell stage). This is also confirmed in our study from the images of four-cell stage embryos at 4-h post cell injection (Fig. 2D) . We noticed that all four-cell 4N embryos developed to compacted embryos, losing their clear blastomeric boundaries. The early compaction of 4N embryos might have influenced the success 
FIG. 5. Representative full-term ntES-4N pups generated by injecting
LDLr KO ntES cells into 4N blastocyst stage embryos and body and placenta weights of LDLr KO ntES pups generated by 4N complementation. A) Pregnant recipient mouse harboring E18.5 4N mice before Csection. Ten ntES-4N pups before (A 0 ) and after (A 00 ) removal from uterine horns of the recipient mouse. B) Fetal and placental weights (mean 6 SD) of 4N pups from 4N complementation at various host embryonic stages. 
ES-4N MICE FROM ES CELLS INJECTED TO VARIOUS STAGE
rate of 4N-ntES pup generation. To test whether prolonging embryo decompaction could facilitate cell incorporation into embryos and improve ntES-4N pup generation, we performed a ''decompaction'' experiment in which we artificially and temporally erased the embryo compaction status and conducted ntES cell injections. As shown in Figure 6 , A and B, once compacted embryos were exposed to calcium-free medium, the embryo morphologically changed, and blastomeric boundaries re-formed (Fig. 6C ). When these embryos were used for ntES-4N pup generation, no significant differences were observed for either the percentage of residual implantation sites or the ntES-4N pup generation rates (Table 2 ). It is possible that even though we could temporally reverse embryo compaction morphologically, the 4N embryos at the four-cell compacted stage had already initiated cellular polarization, which restricted incorporation of the injected ntES cells into the inner cell mass, and therefore we were not able to improve the efficiency. To test this hypothesis, we performed immunostaining to monitor the dynamic changes of cytoskeleton during 4N embryo development (Fig. 7) . Before embryo compaction at the late four-cell stage, microtubules were homogeneously distributed, and microfilaments were concentrated under the cell membranes, especially at the cell-cell contacts in both two-cell and early four-cell 4N embryos (Fig.  7, A and B) . When 4N embryos reached the late four-cell stage, both microtubules and microfilaments showed strong accumulation in the apical portions of the blastomeres. Additionally, the nuclei also translocated from the center to the outer region of the blastomeres (Fig. 7C) . As the embryos developed to fully compacted morulae, cellular polarization status was more obvious (Fig. 7E) . Intriguingly, embryos that were subjected to decompaction treatment showed clear blastomeric boundaries as precompacted four-cell embryos but retained the cytoskeleton distribution of compacted embryos (Fig. 7D ). This result indicates that cellular polarization could not be altered by decompaction treatment.
DISCUSSION
In this study, we aimed to improve the 4N complementation assay by introducing ES or ntES cells into 4N embryos at earlier stages than the conventionally used blastocyst stage. We showed that the 4N embryos at the two-cell and four-cell stages can incorporate the injected ES cells and produce full-term ES-4N pups. Our results also revealed that the two-cell stage embryos were equally efficient as the blastocysts but that the four-cell stage embryos were slightly less efficient in the generation of 4N-ntES mice (Table 1) . Although inbred strains such as C57BL/6 are generally less efficient than outbred or hybrid strains in 4N complementation [12] , we obtained higher 182 ntES-4N pup generation efficiency than reported in previous studies [13, 14] which employed C57BL/6 background ntES cells. This difference may be attributable to the quality of cell lines we chose in this study, an improved ES culture medium that contained knockout serum replacer [4] , and ES cell treatments such as medium refreshing as reported by Ramirez et al. [8] .
In addition, we observed only two full-term ntES-4N mice that could survive to adulthood and then generated F1 offspring through germ-line transmission, which showed agouti coat colors different from the CD1 albino host embryos (Table 1) . There may be two explanations regarding the low survival rate for this observation. First, the ntES cells used were derived from inbred C57BL/6 strain, which are generally believed to have decreased developmental potency compared to ES cell lines from hybrid mouse strain. Previous studies reported no healthy adults from C57BL/6 ES/ntES cells [12, 15] . Another possibility is that E18.5 is 1 day earlier than the natural due date for mouse delivery (E19.5). The reason we performed Csection at E18.5 was to collect all remaining implantation tissues, stillborn fetuses, and live pups. The live pups may be relatively premature compared to those delivered vaginally at E19.5 and have a lower survival rate. Nonetheless, recent work by using four-and eight-cell 2N embryos, such as those reported by Huang et al. [9] and others, increased the contribution of ES cells to the 2N chimera mice. This is a major advance in transgenesis/knockout technology.
Previously, it was believed that the blastocyst stage embryos were the best stage for both 2N chimera generation and 4N complementation. Because of the low efficiency of 4N complementation, attempts to improve it had been made by using later-stage embryos at E3.5-5.5 of pregnancy, equivalent to expanded to hatched blastocysts [16] . It was shown that injection of ES cells into E4.5 embryos gave the highest efficiency. These results, together with ours, support a wide range of embryonic stages, from two cells to E4.5, as suitable for ES cell incorporation into 4N embryos. Therefore, 4N complementation studies can be flexible in scheduling and can be adjusted on the basis of experimental procedures, laboratory circumstances, or schedule preferences.
Experiments conducted in improving 2N chimera generation can be of reference in the improvement of 4N complementation. Recent studies supported the eight-cell stage, which is prior to the embryo compaction event for 2N embryos, as the optimal stage for 2N chimera generation, as opposed to the conventionally used blastocyst stage [3, 8, 9] . Interestingly, this concept is probably not applicable to the 4N embryos, which undergo compaction at the late four-cell stage. We speculated that the relatively short duration of the four-cell stage in 4N embryos may render a narrower window for ES cell incorporation. This assumption could be supported by our decompaction experiment. It is evident that although we could visually reverse embryo compaction time by decompaction treatment, we still could not alter progression of cellular polarization (Fig. 7D) . A previous study has shown that polarized 4N cells have a higher probability to divide conservatively to form polarized cells, which later form the trophectoderm lineage [17] . Therefore, if the ES cells, which we injected into perivitelline space, could not migrate to the inner part of the embryo and integrate into the 4N ICM, the soformed ICM would consist of 4N cells, which will be depleted during development because aneuploid cells will be extruded into the trophoblasts. These embryos would not survive without enough 2N-ES cells to support fetal development. This could support our observation that significantly lower residual implantation sites were formed in the four-cell group than the two-cell or blastocyst group (Table 1) .
Fetal and placenta abnormalities are common observations when the 4N complementation assay is performed. In our experiments, we did not observe abundant large offspring syndrome, open eyelids (Fig. 6D) , or placental hypertrophy phenotypes. Our average ntES-4N pup body and placenta weights from the LDLr KO ntES cell line are much lower than weights reported for ntES-4N pups by Ohta et al. [16, 18] , who observed average body and placenta weights of approximately 1.6 and 0.2 g, respectively, for their ntES-4N pups. The difference may be attributed to the different mouse strains used, inbred C57BL/6 ntES cells in our study, and the mostly hybrid strains, B6129 F1, in theirs.
In conclusion, we explored using earlier stages of 4N embryos for the 4N complementation procedure. We found that the two-cell stage embryos are equally efficient as the conventionally used blastocyst stage. However, the four-cell stage 4N embryos were not as efficient. The low efficiency of the four-cell stage embryos might be due to compaction and polarization. Artificial decompaction did not improve the final outcome.
